Pricing Log in Create free account

Korro Bio, Inc. (KRRO) vs Vanda Pharmaceuticals Inc. (VNDA)

Korro Bio, Inc. and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Vanda Pharmaceuticals Inc. is the larger, with a market value of $231.0M against $202.5M — 1.1× the size. Vanda Pharmaceuticals Inc. grew revenue faster over the last twelve months: 8.11% against −81.9%. Korro Bio, Inc. has the higher net margin (0.00% vs −119.9%) and the higher return on invested capital (0.00% vs −180.2%). Across the 17 metrics below, Korro Bio, Inc. leads on 11 and Vanda Pharmaceuticals Inc. on 6.

Valuation

Metric KRRO VNDA Biotechnology median
P/E n/m n/m 10.60
P/S 40.65 1.01 9.40
P/B 2.52 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 25.53 0.40 9.02
Earnings yield (67.80%) (121.02%) (32.88%)
Free cash flow yield (26.27%) (64.93%) (23.13%)

Profitability

Metric KRRO VNDA Biotechnology median
Gross margin 100.00% 93.59% 68.51%
Operating margin 0.00% (77.59%) 0.00%
Net margin 0.00% (119.87%) 0.00%
Free cash flow margin 0.00% (65.41%) 0.00%
Return on equity (97.69%) (82.55%) (51.96%)
Return on assets (62.03%) (55.89%) (46.06%)
Return on invested capital 0.00% (180.19%) 0.00%

Growth

Metric KRRO VNDA Biotechnology median
Revenue growth (TTM) (81.87%) 8.11% 6.76%
EPS growth (last fiscal year) (33.19%) (1,033.33%) 29.88%
Revenue growth, 5-year CAGR — (2.73%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KRRO VNDA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 9.55 1.54 4.97
Net debt to EBITDA 0.64 1.84 1.01

Dividend

Metric KRRO VNDA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KRRO VNDA Biotechnology median
Market cap 202.45m 230.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack